📬 open to work!
unfortunately, i've been hit by company restructuring and my time at @chainlinklabs has come to an end.
i've thoroughly enjoyed my time working on Chainlink and with some of the most innovative protocols in DeFi; @aave@kamino@ostium@Compound_xyz@eulerfinance@GMX_IO to name a few...
actively seeking senior product roles combining 10+ years of professional expertise across the tech and policy industries to deliver measurable product and business impact
find out more on my website https://t.co/twcmZonuUF or get in touch directly in DM!
DeSci Office hours are back!
No slides, no pitches - just open conversation on how DeSci is evolving.
⏰ 5pm CET/ 8am PST
🎙️ Decentralized Science, AI, DAO updates and more
🗣️ @andreb1o16 & @kiho_rk
https://t.co/65HVoJyqOe
@Mykalt45 @bioebro @artan_bio@vitarnabio@vitadao@Noesslek Think about bioDAOs from the perspective: what could treatments look like if patient organizations funded and owned their own research and treatments. Lots of variety atm in terms of therapeutic areas!
Logan Bishop-Currey of Molecule highlights the gap between academia and industry, where differing incentives and early-stage misalignment can slow biotech progress. Bridging this "valley of death" could save time and resources by ensuring key experiments happen sooner.
We're hosting a DeSci Office Hours tomorrow 🫡
Come chat all things science, tech, DAOs, AI, and more with @andreb1o16 & @kiho6redape
https://t.co/bFY8zCDBvt
We’re excited to announce that the Transfidelity Sponsored Research Agreement was officially signed yesterday, on March 31st.
The project is set to kick off on May 1st, marking a major milestone in our shared journey toward innovation and discovery.
To celebrate this launch and introduce the brilliant minds behind the research, we’ll be hosting a “Meet the Scientists” Spaces within the next two weeks. Stay tuned for details.
We just minted our 3rd IP-NFT - Transfidelity.
1- NEURON-Percepta @Neuron_Percepta
2- NEURON-Fission
3- Transfidelity for Protein Stability
With many more to come! DeSci is all about consistency, long-term vision, and most importantly having a positive impact on the world. 🧠
We are LIVE!
Join us now for the AB4AD Community Call and explore groundbreaking insights into the Alzheimer's Pathogen Hypothesis with Daniel Bar from @vitadao and @Molecule_dao
https://t.co/hMQqVvGCaP
🚨 It’s happening today! 🚨
The AB4AD Community Call kicks off at 7 PM UTC 🎙️
We’re talking:
- Pathogen Hypothesis updates
- Antibodies + Alzheimer’s w/ Dr. Daniel Bar
- Project updates from @vitadao & @Molecule_dao
Don’t miss it. Grab your spot 👇
https://t.co/nGrn3TVK0c
Ab4AD project on @Molecule_dao is breaking new ground in Alzheimer's research 🧬
Early detection through saliva testing could revolutionize diagnosis
Their focus on protective antibodies opens doors for vaccine development
This is what real #biotech innovation looks like
the https://t.co/sU4AVXpPyV arena is open
introducing our first tributes from district 1
$ART CA: 56dS3NpxdCD5f8Nn8zzUFsZRLvhTe9wxNxucUpedrug
$EGS CA: 5B9rz8LXB9mcVsv84NFSeNVbP3wULXNr22xxHqndrug
let the games begin
We've got news! We're launching DeSci Edu—an 8-week program powered by Molecule & @bioprotocol to train the next generation of decentralized science innovators.
If you want to start your career in DeSci, this is for you. 🧵👇